These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9097648)

  • 1. [Objective measurement of visual field by using visual evoked potentials].
    Tobimatsu S
    Nihon Rinsho; 1997 Mar; 55 Suppl 1():450-3. PubMed ID: 9097648
    [No Abstract]   [Full Text] [Related]  

  • 2. Multifocal visual evoked potential in nonorganic visual field loss.
    Massicotte EC; Semela L; Hedges TR
    Arch Ophthalmol; 2005 Mar; 123(3):364-7. PubMed ID: 15767479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal/noise ratios to compare tests for measuring visual field progression.
    Ernest PJ
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6893; author reply 6893-4. PubMed ID: 21123778
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic accuracy of confrontation visual field tests.
    Prasad S; Cohen AB
    Neurology; 2011 Mar; 76(13):1192-3; author reply 1193. PubMed ID: 21444908
    [No Abstract]   [Full Text] [Related]  

  • 5. Signal/noise analysis to compare tests for measuring visual field loss and its progression.
    Artes PH; Chauhan BC
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4700-8. PubMed ID: 19458326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The methodology of visual field testing with frequency doubling technology in the National Health and Nutrition Examination Survey, 2005-2006.
    Terry AL; Paulose-Ram R; Tilert TJ; Johnson CA; Zhang X; Lee PP; Saaddine JB
    Ophthalmic Epidemiol; 2010 Dec; 17(6):411-21. PubMed ID: 21090914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Visual evoked potentials and static perimetry in functional visual deficits].
    Sobolewski P; Stankiewicz A
    Klin Oczna; 1998; 100(4):221-4. PubMed ID: 9770981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migrainous prolonged and reversible bilateral inferior altitudinal visual field defect.
    Razeghinejad MR; Masoumpour M; Bagheri MH
    Headache; 2009 May; 49(5):773-6. PubMed ID: 19178575
    [No Abstract]   [Full Text] [Related]  

  • 9. A review of current technology used in evaluating visual function in glaucoma.
    Turalba AV; Grosskreutz C
    Semin Ophthalmol; 2010; 25(5-6):309-16. PubMed ID: 21091017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Objective evaluation of the visual field defects in a patient with cerebral infarction using multifocal VEPs].
    Yukawa E; Saitou K; Kim YJ; Maruoka S; Kanzaki M; Hara Y
    No To Shinkei; 2006 May; 58(5):408-12. PubMed ID: 16780052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The groningen longitudinal glaucoma study III. The predictive value of frequency-doubling perimetry and GDx nerve fibre analyser test results for the development of glaucomatous visual field loss.
    Heeg GP; Jansonius NM
    Eye (Lond); 2009 Aug; 23(8):1647-52. PubMed ID: 19011607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rarebit perimetry for bedside testing: comparison with standard automated perimetry.
    Steven Houston SK; Weber ED; Koga SF; Newman SA
    J Neuroophthalmol; 2010 Sep; 30(3):243-7. PubMed ID: 20548245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnosis of psychogenic visual problems in children and young adults with application of visual evoked responses (VER)].
    Gotz-Wieckowska A; Bernardczyk-Meller J; Dziedzic-Szeszuła E; Cymerys E
    Klin Oczna; 1999; 101(2):123-6. PubMed ID: 10418237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Topographic mapping of visual evoked potentials in the diagnosis of visual system diseases].
    Krivosheev AA
    Vestn Oftalmol; 2001; 117(3):50-4. PubMed ID: 11521443
    [No Abstract]   [Full Text] [Related]  

  • 15. Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy.
    Sergott RC; Bittman RM; Christen EM; Sagar SM
    Epilepsy Res; 2010 Dec; 92(2-3):170-6. PubMed ID: 20951555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target visual field: a technique to rapidly demonstrate nonorganic visual field constriction.
    Hsu JL; Haley CM; Foroozan R
    Arch Ophthalmol; 2010 Sep; 128(9):1220-2. PubMed ID: 20837813
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of multifocal visual evoked potential tests in the objective evaluation of the visual field in pediatric epilepsy surgery.
    Kim YJ; Yukawa E; Kawasaki K; Nakase H; Sakaki T
    J Neurosurg; 2006 Mar; 104(3 Suppl):160-5. PubMed ID: 16572632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual evoked response studies in assessment of visual field defects.
    Goodwin JA; Glazer JS
    Trans Am Neurol Assoc; 1977; 102():153-7. PubMed ID: 616099
    [No Abstract]   [Full Text] [Related]  

  • 19. Modified visual field trend analysis.
    De Moraes CG; Ritch R; Tello C; Liebmann JM
    J Glaucoma; 2011; 20(4):203-6. PubMed ID: 20520567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovative evaluation of visual field defects in epileptic patients after standard anterior temporal lobectomy, using partial field visual evoked potentials.
    Báez Martín MM; del Carmen Pérez Téllez Y; Chacón LM; Díaz BE; Trápaga-Quincoses O; Maeso IG; Bender JE; Galvizu R; García ME; Abreu IC; Rodríguez GS
    Epilepsy Res; 2010 Jun; 90(1-2):68-74. PubMed ID: 20427151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.